1. Fitzpatrick's dermatology in general medicine. 8th ed. New York: Mc Graw
Hill Medical; 2012. 2. James WD, Berger TG, Eiston DM. Andrews diseases of the skin clinical dermatology. 11th ed.: Saunders Elsevier; 2011. 3. Sperling L. Hair and systemic disease: Dermatologic Clinic; 2001. 4. Hutapea S, Rosita C. Telogen Efluvium. Berkala Ilmu Kesehatan Kulit Kelamin. 2011 April; 23. 5. Ivanivna FM, Petrivna ON, Mykolaivna FS. Study of vasodilating and regenerative effect of the gel with nettle juice intended for telogen effluvium treatment. Jornal of Applied Pharmaceutical Science. 2018 January; 8. 6. Malkud S. Telogen effluvium: a review. Journal of Clinical and Diagnostic Research. 2015 September; 9. 7. GR T, CR K, EK V. Examination of fluconazole-induced alopecia in an animal model and human cohort. Antimcrobial agent and chemotheraphy. 2019 February; 2. 8. A A, F K, S S. Research on the balance of thiol-fisulfide in blood serum in women with telogen effluvium. International Journal of Trichology. 2016. 9. T D, K D. Telogen effluvium with dysesthesia (TED) has lower b12 levels and may respond to b12 supplementation. Journal of drugs dermatology. 2018 January; 11. 10. PM R, E F, C M, M S. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. Jornal of the European Academy of Dermatology and Venerology. 2019 Maret ; 3. x
Advances in Veterinary Dermatology, Volume 7: Proceedings of the Seventh World Congress of Veterinary Dermatology, Vancouver, Canada, July 24 - 28, 2012